| Inhibition of tumor metastasis: functional immune modulation of the CUB domain containing protein 1 K Fukuchi, SCJ Steiniger, E Deryugina, Y Liu, CA Lowery, C Gloeckner, ... Molecular pharmaceutics 7 (1), 245-253, 2010 | 30 | 2010 |
| Fundamental characteristics of the expressed immunoglobulin VH and VL repertoire in different canine breeds in comparison with those of humans and mice SCJ Steiniger, WE Dunkle, GF Bammert, TL Wilson, A Krishnan, ... Molecular immunology 59 (1), 71-78, 2014 | 25 | 2014 |
| Selection of human antibodies against cell surface-associated oligomeric anthrax protective antigen SCJ Steiniger, LJ Altobell III, B Zhou, KD Janda Molecular immunology 44 (10), 2749-2755, 2007 | 24 | 2007 |
| Targeting activated integrin αvβ3 with patient-derived antibodies impacts late-stage multiorgan metastasis K Staflin, JS Krueger, J Hachmann, JS Forsyth, M Lorger, SCJ Steiniger, ... Clinical & experimental metastasis 27, 217-231, 2010 | 16 | 2010 |
| Comparative analysis of the feline immunoglobulin repertoire SCJ Steiniger, J Glanville, DW Harris, TL Wilson, GC Ippolito, SA Dunham Biologicals 46, 81-87, 2017 | 8 | 2017 |
| Interleukin-31 monoclonal antibodies for veterinary use GF Bammert, SA Dunham, SCJ Steiniger US Patent 11,530,262, 2022 | 4 | 2022 |
| Anti-NGF antibodies and methods thereof SCJ Steiniger, W Dunkle, C Rugg, SA Dunham US Patent 10,982,002, 2021 | 4 | 2021 |
| Interleukin-31 monoclonal antibodies for veterinary use GF Bammert, SA Dunham, SCJ Steiniger US Patent App. 17/571,117, 2022 | 1 | 2022 |
| ANTI-PROGRAMMED DEATH-LIGAND 1 (PD-L1) ANTIBODY MOLECULES, ENCODING POLYNUCLEOTIDES, AND METHODS OF USE S STEINIGER, N SUSLOV, A TEPLYAKOV, A THORNE, J LAPETODA, ... WO Patent WO/2023/159,182, 2023 | | 2023 |
| Anti-NGF Antibodies and Methods Thereof SCJ Steiniger, W Dunkle, C Rugg, SA Dunham US Patent App. 17/199,732, 2021 | | 2021 |
| Anti-NGF Antibodies and Methods Thereof SCJ Steiniger, W Dunkle, C Rugg, SA Dunham US Patent App. 17/193,442, 2021 | | 2021 |
| Anti-NGF Antibodies and Methods Thereof SCJ Steiniger, W Dunkle, C Rugg, SA Dunham US Patent App. 17/193,544, 2021 | | 2021 |
| Anti-NGF Antibodies and Methods Thereof SCJ Steiniger, W Dunkle, C Rugg, SA Dunham US Patent App. 17/191,972, 2021 | | 2021 |
| Anti-NGF Antibodies and Methods Thereof SCJ Steiniger, W Dunkle, C Rugg, SA Dunham US Patent App. 17/192,368, 2021 | | 2021 |
| Anti-NGF Antibodies and Methods Thereof SCJ Steiniger, W Dunkle, C Rugg, SA Dunham US Patent App. 17/190,618, 2021 | | 2021 |
| Anti-NGF Antibodies and Methods Thereof SCJ Steiniger, W Dunkle, C Rugg, SA Dunham US Patent App. 17/197,358, 2021 | | 2021 |
| Anti-NGF Antibodies and Methods Thereof SCJ Steiniger, W Dunkle, C Rugg, SA Dunham US Patent App. 17/196,135, 2021 | | 2021 |
| Anticorpos monoclonais de interleucina-31 para uso veterinário GF Bammert, SA Dunham, SCJ Steiniger | | 2021 |
Guy SalvesenProfessor, Sanford-Burnham Medical Research Institutesbpdiscovery.org의 이메일 확인됨
